Achaogen Inc.

Achaogen Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.97
Market Cap
$216.55 M
Shares Outstanding
45.21 M
Public Float
24.99 M

Profile

Address
1 Tower Place
South San Francisco California 94080
United States
Employees -
Website http://www.achaogen.com
Updated 09/14/2018
Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood stream infections, and other infections due to MDR Enterobacteriaceae. The company was founded by Nathaniel E.

Financials

View All
Created with Highcharts 5.0.14Achaogen Inc.Net Income. Fiscal year is January-December. All values USD Thousands.13 11213 11220 17620 17627 09327 09371 22771 227125 618125 61820132014201520162017025k50k75k100k125k150k
Created with Highcharts 5.0.14Achaogen Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.18 51218 51219 97019 97026 06126 06141 77341 77311 17511 17520132014201520162017010k20k30k40k50k

Kenneth J. Hillan
President & Director
Blake Wise
Chief Executive Officer & Director